Second-generation antipsychotic AE monitoring adequate?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.650, 2012-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-generation antipsychotic AE monitoring adequate?

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Switching Between Second-Generation Antipsychotics: Why and How?

By Monika Edlinger Susanne Baumgartner Nadja Eltanaihi-Furtmüller Martina Hummer W. Wolfgang Fleischhacker

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 27-42

Adis International

Access to resources Recommend Favorite

Second-generation antipsychotic prescribing on the increase

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 560, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Second-Generation Antipsychotics: Is There Evidence for Sex Differences in Pharmacokinetic and Adverse Effect Profiles?

By Aichhorn Wolfgang Whitworth Alexandra B. Weiss Elisabeth M. Marksteiner Josef

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 587-598

Adis International

Access to resources Recommend Favorite

What is an Adequate Trial with Clozapine?: Therapeutic Drug Monitoring and Time to Response in Treatment-Refractory Schizophrenia

By Schulte Peter F.J.

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite